FR09C0022I1 - - Google Patents
Info
- Publication number
- FR09C0022I1 FR09C0022I1 FR09C0022C FR09C0022I1 FR 09C0022 I1 FR09C0022 I1 FR 09C0022I1 FR 09C0022 C FR09C0022 C FR 09C0022C FR 09C0022 I1 FR09C0022 I1 FR 09C0022I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3282096P | 1996-12-11 | 1996-12-11 | |
| US08/886,933 US6071904A (en) | 1996-12-11 | 1997-07-02 | Process for manufacturing ophthalmic suspensions |
| PCT/US1997/015727 WO1998025620A1 (en) | 1996-12-11 | 1997-09-05 | Process for manufacturing ophthalmic suspensions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR09C0022I1 true FR09C0022I1 (cs) | 2009-09-25 |
| FR09C0022I2 FR09C0022I2 (cs) | 2010-06-11 |
Family
ID=26708929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR09C0022C Active FR09C0022I2 (cs) | 1996-12-11 | 2009-05-25 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6071904A (cs) |
| EP (1) | EP0941094B1 (cs) |
| JP (1) | JP3611863B2 (cs) |
| AT (1) | ATE209917T1 (cs) |
| CA (1) | CA2274680C (cs) |
| DE (2) | DE69708912T2 (cs) |
| DK (1) | DK0941094T3 (cs) |
| ES (1) | ES2169416T3 (cs) |
| FR (1) | FR09C0022I2 (cs) |
| LU (1) | LU91554I2 (cs) |
| NL (1) | NL300388I2 (cs) |
| PT (1) | PT941094E (cs) |
| WO (1) | WO1998025620A1 (cs) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000001365A1 (en) * | 1998-06-30 | 2000-01-13 | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) | Prolonged release ophthalmic compositions containing a fluoroquinolone |
| PT1392355E (pt) | 2001-05-21 | 2007-03-30 | Alcon Inc | Utilização de inibidores do proteassoma para tratar distúrbios associados à secura ocular |
| US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
| US7112588B2 (en) * | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
| BR0209882A (pt) * | 2001-05-21 | 2004-06-08 | Alcon Inc | Método para o tratamento de distúrbios de olho seco |
| CN1509462A (zh) | 2001-05-21 | 2004-06-30 | NF-κB抑制剂在治疗干眼疾病中的用途 | |
| TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
| JP2005523295A (ja) * | 2002-03-01 | 2005-08-04 | ノバガリ、ファルマ、エスアー | 難溶性薬剤の自己乳化型薬物送達システム |
| DE602004013420T2 (de) | 2003-01-21 | 2009-06-04 | Senju Pharmaceutical Co., Ltd. | Wässrige flüssige zubereitung mit 2-amino-3-(4-bromobenzoyl)phenylessigsäure |
| EP1574222B1 (en) * | 2004-03-12 | 2011-02-09 | Cipla Ltd. | Sterilization process for steroids |
| PT1891939E (pt) * | 2006-07-28 | 2013-10-07 | Novagali Pharma Sa | Composições contendo compostos de amónio quaternário |
| WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
| TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
| TWI489997B (zh) * | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸－多元醇錯合物之水性藥學組成物 |
| US8614210B2 (en) * | 2009-12-03 | 2013-12-24 | Lupin Limited | Process for preparing pharmaceutical ophthalmic compositions |
| EP2394637A1 (en) * | 2010-05-21 | 2011-12-14 | Zaklady Farmaceutyczne Polpharma SA | Process for obtaining sterile brinzolamide suspensions |
| US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| DK2598118T3 (en) | 2010-07-29 | 2018-12-10 | Allergan Inc | CONSERVATIVE-FREE BIMATOPROST AND TIMOLOL SOLUTIONS |
| WO2012053011A2 (en) | 2010-10-18 | 2012-04-26 | Usv Limited | Ophthalmic compositions comprising brinzolamide |
| US20130065888A1 (en) | 2011-08-15 | 2013-03-14 | Biserka Cetina-Cizmek | Ophthalmic formulations and processes for their preparation |
| EP2638909A1 (en) | 2012-03-15 | 2013-09-18 | Azad Pharmaceutical Ingredients AG | Process for preparing sterile Brinzolamide |
| GR1007906B (el) | 2012-03-22 | 2013-05-30 | Φαρματεν Αβεε, | Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου |
| WO2013168186A1 (en) | 2012-05-09 | 2013-11-14 | Icrom Spa | Production of sterile active pharmaceutical ingredients |
| WO2013175285A1 (en) | 2012-05-21 | 2013-11-28 | Aurobindo Pharma Limited | Process for preparing ophthalmic suspension of brinzolamde |
| EP2906198B1 (en) | 2012-10-11 | 2019-04-03 | Indoco Remedies Limited | A process for manufacturing sterile brinzolamide ophthalmic suspension |
| CN104721136A (zh) * | 2013-02-21 | 2015-06-24 | 四川大学 | 一种布佐林胺眼用纳米混悬剂及其制备方法 |
| EA030535B1 (ru) * | 2013-10-17 | 2018-08-31 | Сентисс Фарма Прайвет Лимитед | Не содержащий консерванта офтальмологический фармацевтический состав |
| US9820991B2 (en) * | 2013-11-08 | 2017-11-21 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
| US10463674B2 (en) | 2013-11-08 | 2019-11-05 | Sentiss Pharma Private Limited | Process for manufacturing sterile ophthalmic pharmaceutical suspensions |
| PT3096740T (pt) * | 2014-01-24 | 2020-12-24 | Sentiss Pharma Private Ltd | Composição farmacêutica que compreende brinzolamida |
| PL407710A1 (pl) | 2014-03-28 | 2015-10-12 | Instytut Farmaceutyczny | Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem |
| JP6279395B2 (ja) * | 2014-05-01 | 2018-02-14 | 東亜薬品株式会社 | ブリンゾラミド懸濁性点眼液組成物の製造方法 |
| ES2954412T3 (es) | 2014-10-20 | 2023-11-22 | Sentiss Pharma Private Ltd | Solución oftálmica |
| TWI700085B (zh) * | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
| CN107582519A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 一种布林佐胺滴眼液制剂及其制备方法 |
| GR1009419B (el) | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
| EP3784286A4 (en) | 2018-04-25 | 2022-03-02 | Shilpa Medicare Limited | OPHTHALMIC COMPOSITIONS OF BRINZOLMIDE |
| GR1009616B (el) * | 2018-07-20 | 2019-10-11 | Φαρματεν Α.Β.Ε.Ε. | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου |
| MX2021014477A (es) | 2019-05-29 | 2022-01-06 | Lupin Ltd | Nanoemulsion gelificante in situ de brinzolamida. |
| US20220105101A1 (en) * | 2020-10-05 | 2022-04-07 | Somerset Therapeutics, Llc | Efficient brinzolamide and brimonidine compositions |
| WO2024236599A1 (en) | 2023-05-16 | 2024-11-21 | Micro Labs Limited | Ophthalmic solution of brinzolamide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
| IL101537A (en) * | 1991-04-17 | 1997-11-20 | Merck & Co Inc | OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST |
| DK0625903T3 (da) * | 1992-02-21 | 1999-05-10 | Alcon Lab Inc | Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere |
| US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
| US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| US5429824A (en) * | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
-
1997
- 1997-07-02 US US08/886,933 patent/US6071904A/en not_active Expired - Lifetime
- 1997-09-05 DE DE69708912T patent/DE69708912T2/de not_active Expired - Lifetime
- 1997-09-05 AT AT97939835T patent/ATE209917T1/de active
- 1997-09-05 CA CA002274680A patent/CA2274680C/en not_active Expired - Lifetime
- 1997-09-05 DK DK97939835T patent/DK0941094T3/da active
- 1997-09-05 PT PT97939835T patent/PT941094E/pt unknown
- 1997-09-05 JP JP52598698A patent/JP3611863B2/ja not_active Expired - Lifetime
- 1997-09-05 EP EP97939835A patent/EP0941094B1/en not_active Expired - Lifetime
- 1997-09-05 DE DE122009000016C patent/DE122009000016I1/de active Pending
- 1997-09-05 ES ES97939835T patent/ES2169416T3/es not_active Expired - Lifetime
- 1997-09-05 WO PCT/US1997/015727 patent/WO1998025620A1/en not_active Ceased
-
2009
- 2009-04-22 LU LU91554C patent/LU91554I2/fr unknown
- 2009-05-11 NL NL300388C patent/NL300388I2/nl unknown
- 2009-05-25 FR FR09C0022C patent/FR09C0022I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0941094B1 (en) | 2001-12-05 |
| JP2000501749A (ja) | 2000-02-15 |
| PT941094E (pt) | 2002-05-31 |
| DK0941094T3 (da) | 2002-01-07 |
| ES2169416T3 (es) | 2002-07-01 |
| DE122009000016I1 (de) | 2009-06-25 |
| NL300388I2 (nl) | 2010-02-01 |
| JP3611863B2 (ja) | 2005-01-19 |
| CA2274680A1 (en) | 1998-06-18 |
| FR09C0022I2 (cs) | 2010-06-11 |
| CA2274680C (en) | 2003-11-18 |
| AU718079B2 (en) | 2000-04-06 |
| ATE209917T1 (de) | 2001-12-15 |
| EP0941094A1 (en) | 1999-09-15 |
| US6071904A (en) | 2000-06-06 |
| LU91554I2 (fr) | 2009-06-22 |
| DE69708912T2 (de) | 2002-04-11 |
| AU4183897A (en) | 1998-07-03 |
| DE69708912D1 (de) | 2002-01-17 |
| WO1998025620A1 (en) | 1998-06-18 |
| HK1019704A1 (en) | 2000-02-25 |
| NL300388I1 (nl) | 2009-07-01 |